possibility of complex medicamental and endovascular treatment of pulmonary hypertension in takayasu arteritis with predominant pulmonary arteries’ lesion

点击量: 411
ID: 162229
2020
免费 PDF
文章质量与表现指标
综合质量
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI质量评估
未分析
Readership in this journal
Emerging

Ranked #6 of 34 articles by views in indian journal of chemical technology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
摘要
Takayasu arteritis (TA) is a systemic vasculitis with predominatly lesions of aorta and its large branches. In some cases pulmonary arteries (PA) are involved in the pathological inflammatory process and lead to the formation of pulmonary hypertension and significantly worse the prognosis. Timely development of lesion of PA, appointment of adequate therapy and surgical treatment can prevent irreversible damage of blood vessels and improve the prognosis. Perioperative administration of interleukin-6 inhibitor inhibitor (tocilizumab) in at patients with indications for vascular surgery, including angioplasty PA, should be considered as a promising approach to control the inflammatory activity of TA, reduce the dose of glucocorticoids and the risk of postoperative complications. We present the clinical experience of significant improvement in the patients condition was achieved by using two-stage balloon angioplasty on the background of control of the disease activity with interleukin-6 tocilizumab intravenously and specific therapy with riociguat and iloprost.
参考键
rtynuk2020possibility 使用此键在稿件中自动引用，同时使用 SciMatic 稿件管理器或论文管理器
作者 T. V. Маrtynuk, A. M. Aleevskaya, V. V. Gramovich, N. M. Danilov, I. Z. Korobkova, U. G. Matchin, L. V. Solodovnikova, T. V. Beketova
Are you one of these authors? Claim your profile
期刊 indian journal of chemical technology
年份 2020
DOI
10.26442/00403660.2020.05.000623
URL
https://ter-arkhiv.ru/0040-3660/article/viewFile/34589/pdf
关键词
pulmonary hypertension tocilizumab

引用

未找到引用。如需添加引用，请联系管理员 info@scimatic.org

评论

暂无评论。成为第一个评论此文章的人。